Taran Therapeutics

This positions LENZ as a potential valuable medicine in the fight against a range of serious and life threatening leukemias and associated conditions. Further, research is pointing to myeloid conditions being associated with prior chemotherapy, opening up the possibility of yet further potential uses. While LENZ has not yet been approved for marketing, it is in the final stages of development and further studies in other conditions may follow. The company is preparing to approach various regu...